Novel Siderophore Cephalosporin Nets Promising Results in Tough-to-Treat CRAB

(MedPage Today) -- WASHINGTON – Cefiderocol (Fetroja) may be a viable targeted-therapy option in critically ill patients with carbapenem-resistant Acinetobacter baumannii infections (CRAB), according to the ongoing PROVE trial. In the real...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news